Goel, Sanjay http://orcid.org/0000-0002-2798-7568
Swami, Umang
Kumar, Kirushna
Dittrich, Christian
Reyderman, Larisa
Jain, Minish
Aisner, Joseph
Song, James
Petrylak, Daniel P.
Clinical trials referenced in this document:
Documents that mention this clinical trial
A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer
https://doi.org/10.1007/s00280-019-03877-4
Funding for this research was provided by:
Eisai Inc.
Article History
Received: 27 November 2018
Accepted: 17 May 2019
First Online: 12 June 2019
Compliance with ethical standards
:
: Sanjay Goel: received funding for the study from Eisai Inc. Kirushna Kumar: received grant for conducting the study from Eisai. Christian Dittrich: received an unrestricted research grant from Eisai. Larisa Reyderman: employee of Eisai Inc. Joseph Aisner: received remuneration for DMC panels from Bristol-Myers Squibb and Merck-Serono. James Song: former employee of Eisai Inc. Daniel P. Petrylak: received consultant fees from AstraZeneca, Bayer, Bellicum, Dendreon, Exelixis, Ferring, Johnson and Johnson, Lilly, Medivation, Millennium, Pfizer, Roche Laboratories, and Sanofi Aventis (Tyme pharmaceuticals discontinued 1/31/17). Received grant support from Agensys, AstraZeneca, Bayer, Clovis, Dendreon, Eli Lilly, Endocyte, Genentech, Innocrin, Johnson and Johnson, Lilly, MedImmune, Medivation, Merck, Millennium, Novartis, Pfizer, Progenics, Roche Laboratories, Sanofi Aventis, and Sotio. Has ownership interest/investment in Bellicum, Tyme. Umang Swami and Minish Jain: no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study.